These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 21953616)
1. A phase and frequency alignment protocol for 1H MRSI data of the prostate. Wright AJ; Buydens LM; Heerschap A NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616 [TBL] [Abstract][Full Text] [Related]
2. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis. Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280 [TBL] [Abstract][Full Text] [Related]
3. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification. Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096 [TBL] [Abstract][Full Text] [Related]
4. Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe. Arteaga de Castro CS; Boer VO; Luttje MP; van der Velden TA; Bhogal A; van Vulpen M; Luijten PR; van der Heide UA; Klomp DW NMR Biomed; 2014 Nov; 27(11):1353-60. PubMed ID: 25212868 [TBL] [Abstract][Full Text] [Related]
5. Automated vs. manual pattern recognition of 3D (1)H MRSI data of patients with prostate cancer. Zechmann CM; Menze BH; Kelm BM; Zamecnik P; Ikinger U; Giesel FL; Thieke C; Delorme S; Hamprecht FA; Bachert P Acad Radiol; 2012 Jun; 19(6):675-84. PubMed ID: 22578226 [TBL] [Abstract][Full Text] [Related]
6. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence. Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699 [TBL] [Abstract][Full Text] [Related]
7. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience. Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829 [TBL] [Abstract][Full Text] [Related]
8. Effect of gold marker seeds on magnetic resonance spectroscopy of the prostate. Hossain M; Schirmer T; Richardson T; Chen L; Buyyounouski MK; Ma CM Int J Radiat Oncol Biol Phys; 2012 May; 83(1):451-8. PubMed ID: 22245188 [TBL] [Abstract][Full Text] [Related]
9. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation. Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874 [TBL] [Abstract][Full Text] [Related]
12. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla. Near J; Romagnoli C; Bartha R Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876 [TBL] [Abstract][Full Text] [Related]
13. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology. Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624 [TBL] [Abstract][Full Text] [Related]
14. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954 [TBL] [Abstract][Full Text] [Related]
15. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score. Selnaes KM; Gribbestad IS; Bertilsson H; Wright A; Angelsen A; Heerschap A; Tessem MB NMR Biomed; 2013 May; 26(5):600-6. PubMed ID: 23280546 [TBL] [Abstract][Full Text] [Related]
16. Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T. Lagemaat MW; Zechmann CM; Fütterer JJ; Weiland E; Lu J; Villeirs GM; Holshouser BA; van Hecke P; Lemort M; Schlemmer HP; Barentsz JO; Roell SO; Heerschap A; Scheenen TW J Magn Reson Imaging; 2012 Jan; 35(1):166-73. PubMed ID: 21960013 [TBL] [Abstract][Full Text] [Related]
17. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching. Scheidler J; Vogel M; Gross P; Heuck A Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482 [TBL] [Abstract][Full Text] [Related]